Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Lasers in Medical Science
Published in: Lasers in Medical Science 1/2015

01-01-2015 | Original Article

180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL

Authors: Bulent Altay, Bulent Erkurt, Murat Can Kiremit, Vahit Guzelburc, Mustafa Yucel Boz, Selami Albayrak

Published in: Lasers in Medical Science | Issue 1/2015

Login to get access

Abstract

The purpose of the current study was to evaluate the efficacy and safety of laser prostatectomy by using the latest 180-W XPS GreenLight laser with the new MoXy fiber in the surgical treatment of glands larger than 80 mL in a prospective study. From December 2011 to May 2013, 68 consecutive patients with a mean age of 71.1 ± 9.8 years (range 49 to 85) underwent 180-W XPS laser prostatectomy at our institution. The baseline characteristics, perioperative data, and complications were recorded. Evaluation of outcomes was assessed at 3, 6, and 12 months postoperatively comparing subjective (International Prostate Symptom Score [IPSS], International Index of Erectile Function-5 [IIEF-5]) and objective (Maximal flow rate [Qmax], postvoid residual urine [PVR], transrectal ultrasound [TRUS] volume) parameters to the preoperative data. Mean preoperative prostate volume was 104.3 ± 29.7 mL (range 81 to 185). Mean operation time was 65.5 ± 29.6 min (range 38 to 124), with a mean energy delivery of 398 ± 169 kJ (range 39 to 523). The catheterization time was 20.8 ± 1.9 h (range 6 to 92) and the hospital stay was 27.3 ± 8.7 h (range 12 to 80). No major intraoperative complications were observed. Improvement in IPSS, Qmax, and PVR was statistically significant (p < 0.001) at 3, 6, and 12 months. Urethral strictures were observed in two patients (2.9 %). No patients required reintervention due to residual adenoma. The average volume reduction was 40.5 % at 12 months. Photoselective vaporization of the prostate (PVP) using the new 180-W XPS GreenLight laser system seems to be a safe and effective procedure and could play an important role in the surgical treatment of symptomatic benign prostatic hyperplasia (BPH) patients with larger prostate volumes.
Literature
1.
Sagnier PP, Girman CJ, Garraway M et al (1996) International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 29:15–20PubMed
2.
Berry SJ, Coffey DS, Walsh PC et al (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479PubMed
3.
Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53:160–166PubMedCrossRef
4.
Ahyai SA, Gilling P, Kaplan SA et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397PubMedCrossRef
5.
Thangasamy IA, Chalasani V, Bachmann A et al (2012) Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 62:315–323PubMedCrossRef
6.
Alivizatos G, Skolarikos A, Chalikopoulos D et al (2008) Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study. Eur Urol 54:427–437PubMedCrossRef
7.
Bachmann A, Muir GH, Collins EJ et al (2012) 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 61:600–607PubMedCrossRef
8.
Ruszat R, Seitz M, Wyler SF et al (2008) GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54:893–901PubMedCrossRef
9.
Horasanli K, Silay MS, Altay B et al (2008) Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 71:247–251PubMedCrossRef
10.
Al-Ansari A, Younes N, Sampige VP et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58:349–355PubMedCrossRef
11.
Hueber PA, Ben-Zvi T, Liberman D et al (2012) Mid term outcomes of initial 250 case experience with GreenLight 120 W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: comparison of prostate volumes <60 cc, 60 cc-100 cc and >100 cc. Can J Urol 19:6450–6458PubMed
12.
13.
Malek RS, Barrett DM, Kuntzman RS (1998) High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 51:254–256PubMedCrossRef
14.
Bachmann A, Tubaro A, Barber N et al (2014) 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial—the GOLIATH Study. Eur Urol 65:931–942PubMedCrossRef
15.
Hueber PA, Liberman D, Ben-Zvi T et al (2013) 180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters. Urology 82:1108–1113PubMedCrossRef
16.
Emara AM, Barber NJ (2014) The continuous evolution of the Greenlight laser; the XPS generator and the MoXy laser fiber, expanding the indications for photoselective vaporization of the prostate. J Endourol 28:73–78PubMedCrossRef
17.
Ben-Zvi T, Hueber PA, Liberman D et al (2013) GreenLight XPS 180 W vs HPS 120 W laser therapy for benign prostate hyperplasia: a prospective comparative analysis after 200 cases in a single-center study. Urology 81:853–858PubMedCrossRef
18.
Abdel-Hakim AM, Habib EI, El-Feel AS, Elbaz AG et al (2010) Holmium laser enucleation of the prostate: initial report of the first 230 Egyptian cases performed in a single center. Urology 76:448–452PubMedCrossRef
19.
Taşçı AI, Ilbey YÖ, Luleci H et al (2011) 120-W GreenLight laser photoselective vaporization of prostate for benign prostatic hyperplasia: midterm outcomes. Urology 78:134–140PubMedCrossRef
20.
Spaliviero M, Strom KH, Gu X et al (2010) Does Greenlight HPS (™) laser photoselective vaporization prostatectomy affect sexual function? J Endourol 24:2051–2057PubMedCrossRef
21.
Te AE, Malloy TR, Stein BS et al (2004) Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 172:1404–1408PubMedCrossRef
22.
Elmansy H, Baazeem A, Kotb A et al (2012) Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial. J Urol 188:216–221PubMedCrossRef
23.
Wong C, Araki M, Tonkin JB (2007) High-power potassium-titanyl-phosphate or lithium triboride laser photoselective vaporization prostatectomy for benign prostatic hyperplasia: a systematic approach. J Endourol 21:1141–1144PubMedCrossRef
Metadata
Title
180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL
Authors
Bulent Altay
Bulent Erkurt
Murat Can Kiremit
Vahit Guzelburc
Mustafa Yucel Boz
Selami Albayrak
Publication date
01-01-2015
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 1/2015
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-014-1667-4

Other articles of this Issue 1/2015

Lasers in Medical Science 1/2015 Go to the issue

Original Article

Use digital subtraction images of blue-light and near-infrared autofluorescence for the assessment of irregular foveal contour

Original Article

Effect of phototherapy with light-emitting diodes (890 nm) on tendon repair: an experimental model in sheep

Original Article

Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study

Original Article

Effects of Er:YAG and Er,Cr:YSGG laser irradiation on the adhesion to eroded dentin

Original Article

Combination of a novel photosensitizer DTPP with 650 nm laser results in efficient apoptosis, arresting cell cycle and cytoskeleton protein changes in lung cancer A549 cells

Original Article

Effects of 915 nm GaAs diode laser on mitochondria of human dermal fibroblasts: analysis with confocal microscopy